Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aggressive Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Follicular Lymphoma
• Hodgkin Lymphoma
• Indolent Non-hodgkin Lymphoma
• Lymphoma
• Lymphoplasmacytic Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndrome
• Myelogenous Leukemia
• Myeloproliferative Neoplasm
• Phase Chronic Myeloid Leukemia
• Plasma Cell Myeloma
• Small Lymphocytic Lymphoma
• T-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-10-11